Lexicon Pharmaceuticals (LXRX) Deferred Taxes (2017)
Lexicon Pharmaceuticals (LXRX) reported Deferred Taxes of -$4.0 million for Q4 2017, up 53.21% quarter-over-quarter from -$8.7 million in Q1 2017.
Lexicon Pharmaceuticals (LXRX) Deferred Taxes (2017) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 1 years of Deferred Taxes data on file, last reported at -$4.0 million in Q4 2017.
- Deferred Taxes for Q4 2017 came in at -$4.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2018 was -$4.0 million (up 53.21% YoY), and the FY2019 annual result was -$6.0 million, changed N/A from the prior year.
- Deferred Taxes advanced to -$4.0 million in Q4 2017 per LXRX's latest filing, from -$8.7 million in the prior quarter.
- Over five years, Deferred Taxes peaked at -$4.0 million in Q4 2017 and troughed at -$8.7 million in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -4.05 Mn |
| Mar 31, 2017 | -8.65 Mn |